Literature DB >> 6210829

Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.

C Kettner, E Shaw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6210829     DOI: 10.1016/s0076-6879(81)80065-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  41 in total

1.  Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.

Authors:  L Bergamaschini; S Canziani; B Bottasso; M Cugno; P Braidotti; A Agostoni
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

2.  Peptidyl inverse esters of p-methoxybenzoic acid: a novel class of potent inactivator of the serine proteases.

Authors:  J Lynas; B Walker
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

3.  A specific inhibitor of mammalian kallikrein, Phe-Phe-Arg-chloromethyl ketone, inhibits the production of vasoactive substances from trout plasma by kallikrein and blocks endogenous kallikrein-like activity in trout gills.

Authors:  D W Lipke; K R Olson
Journal:  Fish Physiol Biochem       Date:  1992-12       Impact factor: 2.794

4.  Skeletal muscle and liver contain a soluble ATP + ubiquitin-dependent proteolytic system.

Authors:  J M Fagan; L Waxman; A L Goldberg
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

5.  Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites.

Authors:  F C Portaro; M H Cezari; M A Juliano; L Juliano; A R Walmsley; E S Prado
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

6.  Contribution of blood and systemic circulation to the processing of pro-(atrial natriuretic factor).

Authors:  K K Murthy; G Thibault; M Cantin
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

7.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

Authors:  G M Rodgers; W H Kane
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

8.  Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice.

Authors:  Cristina P Vicente; Li He; Douglas M Tollefsen
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

9.  Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.

Authors:  B E Maryanoff; X Qiu; K P Padmanabhan; A Tulinsky; H R Almond; P Andrade-Gordon; M N Greco; J A Kauffman; K C Nicolaou; A Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

10.  Elevation of synovial plasminogen activator activity after injection of interleukin-1 alpha into rabbit knee joint.

Authors:  V S Ganu; R L Goldberg; V J Blancuzzi; D E Wilson; J Doughty; R Melton; E O'Byrne
Journal:  Agents Actions       Date:  1991-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.